Frontlight ResearchEarly access
WithdrawnNo phase
Suboxone Dispenser for OUD
Key facts
- Who runs it
- Addinex Technologies, Inc.
- Where
- Greenwich, United StatesSee the site
- Trial code
- Status
- Withdrawn
- Started
- 15 Jan 2024
- Ended
- 31 Aug 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Addinex
- Record updated
- 28 May 2025
- Why it stopped
- Study was discontinued at the primary site due to change in site management.
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- A minimum of 18 years old at admission of study
- Primary or secondary diagnosis of opioid use disorder (DSM-5; APA, 2013) diagnosis by clinician
- Prospective patients have to select 'Yes' they are interested in Yale-approved research studies while enrolled at Aware Recovery Care and that researchers can contact them about research projects
Who cannot take part
- Meets criterion of DSM-V (APA, 2013) for bi-polar, schizophrenia, or psychiatric disorders
- Unable to read and understand English at 5th grade level
- Unable to complete the study because of anticipated incarceration or move
- Life threatening or unstable medical problems
- Current suicide or homicide risk
- Anticipated/current pregnancy, or breastfeeding
Where in United States
- Greenwich HospitalGreenwich, United States
About the trial
What the trial wants to find out
The goal of this study is to evaluate the usability and acceptability of the Addinex system with patients receiving Suboxone in OUD treatment. The main questions it aims to answer are:
Read full original descriptionShow less
* Are patients more likely to stay on their medication? * Is the risk of diversion being reduced? * How is the usability of the Addinex system for doctors and patients?
The 2 groups in the trial
- ControlExisting treatment, for comparison
Patients in this arm will undergo standard at-home OUD treatment (n = 5/group) over 14-days.
Treatment: Addinex
- Active - AppTreatment being tested
Patients in this arm will undergo standard at-home OUD treatment in combination with the Addinex dispenser and app (n = 5/group) over 14-days.
Treatment: Addinex
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Development of a Telehealth Medication-assisted Treatment (MAT) System for Patients With Opioid Use Disorder (OUD)
- Record updated
- 28 May 2025